Transformations of N-heteroarylformamidines and N-heteroarylformamidine oximes new syntheses and transformations of oxazolo[4,5—d]pyridazines

New syntheses of oxazolo[4,5—d]pyridazine derivatives7 and11 were achieved by the cyclization of substituted N-pyridazin-5-ylformamide oximes6 and10. Under mild reaction conditions the transformations of the substituted amino group at position 2 of the oxazolo[4,5—d]pyridazine system7 occured to produce the compounds11, 14, and15, while under more drastic reaction conditions the nucleophilic attack at carbon at position 2 followed by the ring opening of the oxazole part of the molecule was observed to give the compounds13, 16, 17 and18.

---

Transformationen von N-Heteroarylformamidinen und N-Heteroarylformamidinoximen. Neue Synthesen und Transformationen von Oxazolo[4,5—d]pyridazinen

Zusammenfassung Mittels Cyclisierung substituierter N-Pyridazin-5-ylformamidoxime6 und10 wurden neue Synthesemöglichkeiten von Oxazolo[4,5—d]pyridazinderivaten erschlossen. Bei milden Reaktionsbedingungen trat Transformation der substituierten Aminogruppe an Position 2 des Oxazolo[4,5—d]pyridazin-Systems unter Bildung der Verbindungen11, 14 und15 ein, währenddessen unter drastischeren Reaktionsbedingungen ein nucleophiler Angriff am Kohlenstoff-2, gefolgt von einer Ringöffnung unter Bildung der Verbindungen13, 16, 17 und18 eintrat.

     

Microencapsulation of astiban acid for the treatment ofSchistosomiasis mansoni

Schistosomiasis is among the top five diseases in the world in terms of morbidity, affecting perhaps 200 million people in tropical and subtropical countries. Antischistosomal drugs are toxic and rapidly metabolized. Hence, they must be given in a number of spaced doses. In spite of this there are severe side effects leading to poor patient compliance. This is an ideal situation for the application of sustained drug release to avoid the toxic peak concentration of drug. This study was carried out using Astiban acid, an antimonial drug that is effective againstS. mansoni. Unfortunately, the drug is sufficiently soluble that 50 mg will dissolve in 100 mL water in less than a minute. To permit sustained release of intramuscularly injected drug, microcapsules of astiban acid in poly(d,l-lactic acid) were formed by coacervation. Release studies show that an appreciable fraction of the drug is available at the surface for rapid solution. After this surface drug dissolves, the remaining drug is released slowly with half-times of many hours. After the initial burst, the release of drug follows Higuchi’s equation up to approximately 80% release, with exponentially decreasing release rates thereafter.     

Synthesis,structure and spin-crossover transition of The Cluster Compound Nb6I11−xBrx (0 ⩽ x ⩽ 2.7)

The homogeneous phase Nb₆I_11?xBr_x (0 ? x ? 2.7) is synthesized from Nb₃Br₈, Nb₃I₈ and Nb in sealed Nb capsules at 1 130 K. A second-order phase transition is found as for the composition Nb₆I₁₁ itself, changing the space group from P2₁cn (low temperatures) to Pccn, accompanied by a spin-crossover from a doublet to a quartet state. With increasing Br content the lattice constants decrease and the transition temperature shifts from 274 to 170 K while the transition interval is broadened simultaneously. Single crystal investigations for x = 0.5 and 2.3, each at 110 and 298 K, indicate a preferred substitution of one of the bridging I positions (I6) by Br atoms.     

Spectrofluorimetric determination of phenyl-<Emphasis Type="Italic">β</Emphasis>-naphthylamine used as rubber antioxidant

Phenyl--naphthylamine (PBN) used as rubber antioxidant was found to have native fluorescence. A spectrofluorimetric method for determination of PBN in multicomponent mixtures of polymer additives is described. The apparent excitation and fluorescence wavelengths used are 348 and 413.5 nm, respectively. Maximum fluorescence intensity is obtained by irradiating PBN dissolved in ethanol, at room temperature. The fluorescence varies linearly with the concentration of PBN in the range of 0.04–4 g mL^–1. The accuracy and precision of the method are reported.     

A Combined Effect of Thermal and Enzymatic Racemization for d‐Aspartic Acid to l‐Aspartic Acid by High‐Performance Liquid Chromatography Assay

The racemization of d ‐aspartic acid to l ‐aspartic acid has been successfully performed with a coupled enzyme system at 90 °C and a pH of about 4.0 by the assay of high‐performance liquid chromatography. This coupled enzymatic racemization is a successive two‐step reaction first induced by d ‐amino acid oxidase and a subsequent coupled reaction by an aminotransferase clonezyme with the help of coenzyme pyridoxal 5′‐phosphate and cosubstrate l ‐glutamate. Due to the very high temperature, part of the l ‐aspartic acid is produced by the thermal effect. In fact the thermal racemization for aspartic acid can proceed from either d ‐ or l ‐aspartic acid via an intermediate fumaric acid and leads to the formation of d ,l ‐malic acid. The formation of α‐oxalacetic acid formed irreversibly from d ‐aspartic acid with d ‐amino acid oxidase can induce a side reaction to l ‐alanine. The thermal effect may also be responsible for the production of d ‐, and l ‐alanine.     

Charge control of phenol complexation with unsaturated compounds containing organosilicon substituents. Thiophene derivatives

The frequency shifts of the O-H stretching modes and the resonance components _R of these shifts in the IR spectra of H-complexes of phenol with thiophene derivatives having organic and organosilicon substituents have been analyzed. Relationship of and _R parameters to values calculated by nonempirical methods that characterize the electronic effect of organic substituents on the effective charges of the thiophene ring atoms has been established. It has been shown that in the complexation of phenol (hard acid) with thiophene derivatives charge control prevails over frontier orbital control. The changes in the effective charges of the thiophene ring atoms due to the effect of organosilicon substituents have been calculated.For the previous publication of this series see Ref. 1.Translated fromIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 12, pp. 2163–2168, December, 1994.This work was supported by the Russian Foundation for Basic Research, Project No. 93-03-18725.     

Inverse method for determining the depth of nonhomogeneous surface layers in elastic solids from the measurements of the dispersion curves of group velocity of surface SH Waves

In this paper, the variational inverse method for determining the depth of nonhomogeneous surface layers in elastic materials, from the measurements of the group velocity of surface shear horizontal (SH) waves, is developed. The direct problem for a given a priori type of profile of the coefficientc44in(x) (e.g. linear, Gaussian, etc.) is solved. The dispersion curves of phase and group velocity of surface SH waves in nonhomogeneous solids are calculated. Experimental verification of the inverse method has been performed for step profiles (structure of Cu on steel). It is stated that the inverse method based on the measurements of group velocity (for step profile) gives a smaller error in the unknown depth of the surface layer than that resulting from the inverse method based on the measurements of phase velocity of surface SH waves.     

Astragalin identification in graviola pericarp indicates a possible participation in the anticancer activity of pericarp crude extracts: In vitro and in silico approaches

Graviola, soursop, or guanabana (Annona muricata L.), is an ethnomedical fruit consumed to alleviate headache, diarrhea, diabetes, and cancer. Pericarp is the inedible part of graviola least studied in comparison to seeds and leaves, even thought, it contains the highest concentration of graviola total polyphenols. Anticancer effect of graviola pericarp has been demonstrated in crude extracts attributing the effect to acetogenins, however, crude extracts contain several active molecules. Thus, the present work aimed to fractionate and purify an ethanolic crude extract from graviola pericarp. Purified graviola pericarp fraction (PGPF) was evaluated on cancerous and non-cancerous cell lines, and then was identified by NMR, TOF-MS, and HPLC. Finally, an in silico analysis was performed to predict targets cancer-related of the molecule detected. Our results revealed IC₅₀ values for cervix adenocarcinoma (HeLa), hepatocellular carcinoma (HepG2), triple-negative breast cancer (MDA-MB-231), and non-cancerous cell line (HaCaT) of 92.85 ± 1.23, 81.70 ± 1.09, 84.28 ± 1.08, and 170.2 ± 1.12 µg PGPF/mL, respectively. In vitro therapeutic indexes estimated as quantitative relationship between safety and efficacy of PGPF were 1.83, 2.08, and 2.02 for HeLa, HepG2, and MDA-MB-231, respectively. The NMR analysis revealed astragalin (kaempferol-3-O-glucoside) in PGPF, a flavonoid not reported in graviola pericarp until now. Astragalin identity was confirmed by TOF-MS and HPLC. In silico results support previous reports about astragalin modulating proteins such as Bcl-2, CDK2, CDK4, MAPK and RAF1. Also, results suggest that astragalin may interact with other cancer-related proteins not associated previously with astragalin. In conclusion, astragalin may be contributing to the anticancer effect observed in graviola pericarp extracts.     

Titanium dioxide plasma treatment

After a review of the literature on titanium production under plasma conditions, the main parameters controlling the reactions (residence time, type and relative quantity of reducer, reaction temperature, etc.) are emphasized. The controlled-atmosphere chamber where the rutile or anatase particles are heated and partly reduced in a crucible by a d.c. plasma torch with Ar-H₂ as plasma gas is described. Study of the temperature dependence of the Gibbs free energy allows one to explain, at least qualitatively, the experimental results obtained which correspond at best to 10% (weight) of TiO₂ reduced to TiO by carbon.